Delivery Order SPE2DB20D1100-SPE2DB24FB0N2
Award Date 4/1/24
Potential Completion Date 4/22/24
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The delivery order is for Envarsus XR 4 mg tablets, a pharmaceutical product, with a firm fixed price of $1,615.33 and a completion date of November 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple IDCs by various federal agencies, including a $999,999,999 IDC with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,379.55 firm-fixed-price delivery order is for the supply of Envarsus XR 0.75 mg tablets, with a period of performance through October 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical for delivering a broad range of medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,516.32 Firm Fixed Price Delivery Order is for the supply of Envarsus XR 1 mg tablets, a medication used in the treatment of certain medical conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Envarsus XR 1 mg tablets (30-count packaging) under a firm fixed-price contract with a ceiling value of $1,637.04. This non-set-aside award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a specialty pharmaceutical product, with a potential value of $2,026.85 and a performance period through March 15, 2024. This delivery order is issued under a larger, single-award indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENVARSUS XR 1 MG TABLET 30S. The order has a completion date of March 4, 2024 and a potential value of $1,465.68. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is part of a larger indefinite delivery contract (IDC)...
- The Defense Logistics Agency awarded a $1,288.86 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for 100 tablets of Envarsus XR 1 mg, a pharmaceutical product used in transplant immunosuppression therapy. This firm fixed price contract with an ultimate completion date of September 17, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- This is a delivery order award worth $6,461.32 to AmerisourceBergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA). The order is for the pharmaceutical product Envarsus XR 4 mg tablet, which is a critical medical supply. The contract has a completion date of September 27, 2024 and is a firm fixed-price contract. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the federal government, particularly the Department of Defense and...
- The Defense Logistics Agency awarded a $1,811.00 delivery order to AmerisourceBergen Drug Corp for Envarsus XR 1 mg tablets (100-count package) on November 18, 2025, with completion scheduled for December 10, 2025. This competitively awarded, firm fixed-price delivery order represents a procurement of a specialized immunosuppressant medication for federal medical supply needs. The award was issued under no set-aside designation, reflecting the contractor's capability to compete openly in the...
- The Defense Logistics Agency (DLA) awarded a $2,432.22 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for Envarsus XR 1 mg tablet 100s. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...